This is an outdated version published on 2022-12-21. Read the most recent version.

Cocaine-levamisole vasculitis, with cutaneous, joint and gastrointestinal manifestations

Case report


Authors

DOI:

https://doi.org/10.22517/25395203.24982

Keywords:

substance-related disorders, vasculitis, cocaine, levamisol

Abstract

Levamisole is an antiparasitic agent for veterinary use that is currently being used to increase the volume and potency of cocaine and thus obtain more profits in its commercialization. The mixture of these two substances can cause in the organism the cocaine-levamisole syndrome, which is characterized by cocaine-like lesions such as the involvement of the septal cartilage and perforation of the nasal septum, cutaneous vasculitis of small vessels as well as a specific vasculitic involvement. of auricular pavilions and nasal cartilage that can progress to necrosis and even ulceration associated with agranulocytosis, arthralgias and rarely glomerulonephritis. In this case, a vasculitis syndrome associated with cocaine-levamisole is described, with mainly cutaneous and joint manifestations, as well as gastrointestinal. The patient presented an adequate response with steroids, but before recurrence required additional management with cyclophosphamide for total control of symptoms.

Downloads

Download data is not yet available.

Author Biographies

José Julián Aristizábal-Hernández, MD, MSc, Clínica Universitaria Bolivariana. Universidad Pontificia Bolivariana

Médico.

Especialista en Toxicología Clínica.

Ciencias Clínicas.

 

María Paulina Villa-Saldarriaga, MD, Universidad Pontificia Bolivariana

Médica.

Residente de Medicina Interna.

 

María Carolina Rave-Aguirre, MD, Hospital Santa Margarita, Copacabana, Antioquia

Médica.

Coordinadora de urgencias, Médica del programa atención primaria en salud. Médica de vigilancia epidemiológica. Médica PIC, alcaldía de Copacabana.

Juliana Ceballos-Giraldo, MD, Hospital La María

Médica.

Ana Mercedes Vanegas-Torres, MD, Hospital Marco Fidel Suarez, Bello, Antioquia.

Médica.

Miguel Antonio Mesa-Navas, MD, Clínica SOMER, Rionegro, Antioquia. Clínica del Rosario sede del Tesoro, Medellín, Antioquia. Unidad de Investigación en Reumatologia SURA

Médico. 

Especialista en Medicina Interna

Especialista en Reumatología.

References

Gross RL, Brucker J, Bahce-Altuntas A, Abadi MA, Lipoff J, Kotlyar D, et al. A novel cutaneous vasculitis syndrome induced by levamisole-contaminated cocaine. Clin Rheumatol [Internet]. 2011 [consultado 23 enero 2022];30(10):1385–92. Disponible en: http://link.springer.com/10.1007/s10067-011-1805-3

Quirt IC, Shelley WE, Pater JL, Bodurtha AJ, McCulloch PB, McPherson TA, et al. Improved survival in patients with poor-prognosis malignant melanoma treated with adjuvant levamisole: A phase III study by the National Cancer Institute of Canada clinical trials group. J Clin Oncol [Internet] 1991 [consultado 23 enero 2022];9(5):729–35. Disponible en: http://ascopubs.org/doi/10.1200/JCO.1991.9.5.729

Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Goodman PJ, et al. Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma. N Engl J Med [Internet]. 1990 [consultado 23 enero 2022];322(6):352–8. Disponible en: http://www.nejm.org/doi/abs/10.1056/NEJM199002083220602

Laurie JA, Moertel CG, Fleming TR, Wieand HS, Leigh JE, Rubin J, et al. Surgical adjuvant therapy of large-bowel carcinoma: An evaluation of levamisole and their combination of levamisole and fluorouracil. J Clin Oncol [Internet] 1989 [consultado 23 enero 2022];7(10):1447–56. Disponible en: http://ascopubs.org/doi/10.1200/JCO.1989.7.10.1447

Amery WKP, Bruynseels JPJM. Levamisole, the story and the lessons. Int J Immunopharmacol [Internet] 1992 [consultado 23 enero 2022];14(3):481–6. Disponible en: https://doi.org/10.1016/0192-0561(92)90179-O

United Nations Office on Drugs and Crime. Drug Market Trends: Cocaine, Amphetaminte-Type Stimulants [Internet] 2021[consultado 23 enero 2022]. Disponible en: https://www.unodc.org/res/wdr2021/field/WDR21_Booklet_4.pdf

Junta Internacional de Fiscalización de Estupefacientes (JIFE). Informe [Internet]. 2021. 160 p. Available from: https://www.incb.org/documents/Publications/AnnualReports/AR2020/Annual_Report/E_INCB_2020_1_spa.pdf

Ministerio de Justicia y del Derecho - Observatorio de Drogas de Colombia (ODC). Estudio Nacional de Consumo de Sustancias Psicoactivas en Colombia 2019. Informe final [Internet]. Bogotá DC.; 2019. Disponible en: http://201.217.213.202/Portals/1/publicaciones/pdf/estudio Nacional de consumo 2019.pdf

Chang A, Osterloh J, Thomas J. Levamisole: a dangerous new cocaine adulterant. Clin Pharmacol Ther. 2010;88(3):408-411. doi:10.1038/clpt.2010.156

Spector S, Munjal I, Schmidt DE. Effects of the immunostimulant, levamisole, on opiate withdrawal and levels of endogenous opiate alkaloids and monoamine neurotransmitters in rat brain. Neuropsychopharmacology [Internet] 1998 [cited 2017 November];19(5):417–27. Available from: http://www.nature.com/doifinder/10.1016/S0893-133X(98)00034-7

Mesa MA, Vasquez G. NETosis. Autoimmune Diseases. [Internet]2013 [cited 2017 November]. Available from: https://doi.org/10.1155/2013/651497

Lood C, Hughes GC. Neutrophil extracellular traps as a potential source of autoantigen in cocaine-associated autoimmunity. Rheumatology [Internet]. 2016 [cited 2017 November];56(4):638-643. Available from: https://doi.org/10.1093/rheumatology/kew256

Berman M, Paran D, Elkayam O. Cocaine-Induced Vasculitis. Rambam Maimonides Med J [Internet]. 2016[cited 2017 November];7(4):e0036. Available from: https://doi.org/10.5041/RMMJ.10263

De La Hera I, Sanz V, Cullen D, Chico R, Petiti G, Villar M, et al. Necrosis of ears after use of cocaine probably adulterated with levamisole. Dermatology [Internet]. 2011 [cited 2017 November] ;223(1):25–8. Available from: https://doi.org/10.1159/000329436

Poon SH, Baliog CR, Sams RN, Robinson-Bostom L, Telang GH, Reginato AM. Syndrome of Cocaine-Levamisole-Induced Cutaneous Vasculitis and Immune-Mediated Leukopenia. Semin Arthritis Rheum [Internet]. 2011[cited 2017 November];41(3):434–44. Available from: https://doi.org/10.1016/j.semarthrit.2011.05.009

Muñoz-Vahos CH, Herrera-Uribe S, Arbeláez-Cortés Á, Jaramillo-Arroyave D, González-Naranjo LA, Vásquez-Duque G, et al. Clinical Profile of Levamisole-Adulterated Cocaine-Induced Vasculitis/Vasculopathy: A 30-Case Series. J Clin Rheumatol [Internet]. 2019 [cited 2017 November];25(3):E16–26. Available from: https://doi.org/10.1097/RHU.0000000000000813

Khan TA, Cuchacovich R, Espinoza LR, Lata S, Patel NJ, Garcia-Valladares I, et al. Vasculopathy, hematological, and immune abnormalities associated with levamisole-contaminated cocaine use. Semin Arthritis Rheum [Internet]. 2011 cited 2017 November];41(3):445–54. Available from: https://doi.org/10.1016/j.semarthrit.2011.04.010

Lopera G, Lotero J, Montoya L, Duque M, Restrepo D. Vasculitis y neutropenia asociada al consumo de cocaína adulterada con levamisol: nuevas complicaciones para viejos problemas clínicos. Rev Patol Dual [Internet]. 2016 [citado 2017 noviembre];3(3):1–8. Disponible en: https://doi.org/10.17579/RevPatDual.03.28

Marquez J, Aguirre L, Muñoz C, Echeverri A, Restrepo M, Pinto LF. Cocaine-Levamisole-Induced Vasculitis/Vasculopathy Syndrome [Internet] 2017 [cited 2017 November] Curr Rheumatol Rep ;19(6):36. doi: 10.1007/s11926-017-0653-9

Wiesner O, Russell KA, Lee AS, Jenne DE, Trimarchi M, Gregorini G, et al. Antineutrophil cytoplasmic antibodies reacting with human neutrophil elastase as a diagnostic marker for cocaine-induced midline destructive lesions but not autoimmune vasculitis. Arthritis Rheum [Internet] 2004 [cited 2017 November];50(9):2954–65. Available from: https://onlinelibrary.wiley.com/doi/10.1002/art.20479

Lynch KL, Dominy SS, Graf J, Kral AH. Detection of levamisole exposure in cocaine users by liquid chromatography-tandem mass spectrometry. J Anal Toxicol [Internet]. 2011 [cited 2017 November];35(3):176–8. Available from: https://doi.org/10.1093/anatox/35.3.176

Waller JM, Feramisco JD, Alberta-Wszolek L, McCalmont TH, Fox LP. Cocaine-associated retiform purpura and neutropenia: Is levamisole the culprit? J Am Acad Dermatol [Internet] 2010 [cited 2017 November];63(3):530–5. Available from: https://doi.org/10.1016/j.jaad.2010.01.055

Pavenski K, Vandenberghe H, Jakubovic H, Adam DN, Garvey B, Streutker CJ. Plasmapheresis and steroid treatment of levamisole-induced vasculopathy and associated skin necrosis in crack/cocaine users. J Cutan Med Surg [Internet] 2013 [cited 2017 November];17(2):123–8. Available from: https://doi.org/10.2310/7750.2012.12028

Imbernón-Moya A, Chico R, Aguilar-Martínez A. Manifestaciones cutáneas y mucosas asociadas al consumo de cocaína. [Internet] 2016 [cited 2017 November] Medicina Clinica; 544–9. Available from: https://doi.org/10.1016/j.medcli.2016.02.015

Downloads

Published

2022-10-30 — Updated on 2022-12-21

Versions

How to Cite

Aristizábal-Hernández, J. J., Villa-Saldarriaga, M. P., Rave-Aguirre, M. C., Ceballos-Giraldo, J., Vanegas-Torres, A. M., & Mesa-Navas, M. A. (2022). Cocaine-levamisole vasculitis, with cutaneous, joint and gastrointestinal manifestations: Case report. Revista Médica De Risaralda, 28(2). https://doi.org/10.22517/25395203.24982 (Original work published October 30, 2022)